Navigation Links
Tobira Therapeutics Inc. Announces Key Addition to Scientific Advisory Board
Date:6/4/2009

- Dr. Roscoe M. Moore, Jr. to join Board -

PRINCETON, N.J. and SAN DIEGO, June 4 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the addition of Roscoe Moore Jr., D.V.M., Ph.D., D.Sc. to their Scientific Advisory Board.

"We expect Dr. Moore to contribute significantly to our already robust Scientific Advisory Board. His expertise across all areas of public health and infectious diseases will be a tremendous asset to Tobira Therapeutics," said James Sapirstein, CEO.

Dr. Moore, President, PH RockWood Corporation, Rockville, Maryland and Pretoria, South Africa, is the Former Assistant United States Surgeon General and Rear Admiral, United States Public Health Service (Retired). Until his retirement Dr. Moore, Jr. served with the United States Department of Health and Human Services (HHS) and was for the last twelve years of his career the principal person responsible for development support within the Office of the Secretary, Health and Human Services (HHS). Dr. Moore served as an Epidemic Intelligence Service Officer with the U.S. Centers for Disease Control (CDC) and Prevention. He was with the Center for Veterinary Medicine, U.S. Food and Drug Administration (FDA), before becoming Senior Epidemiologist within the National Institute for Occupational Safety and Health, CDC. He served as the Chief Epidemiologist with the Center for Devices and Radiological Health, FDA. He directed the Epidemiology and Biostatistics Program and was an Assistant Professor of Oncology within the Howard University College of Medicine Cancer Center.

Dr. Moore received his undergraduate and Doctor of Veterinary Medicine degrees from Tuskegee Institute; his Master of Public Health degree in Epidemiology from the University of M
'/>"/>

SOURCE Tobira Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Tobira Therapeutics Inc. Announces Senior Management Team
2. Tobira Therapeutics, Inc. to Present at the 2008 BIO Investor Forum
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
5. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
6. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
7. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
10. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
11. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... Inc. (Nasdaq: MYL ) today announced that it intends ... amount of senior notes through a reopening of its Senior ... notes are being offered as additional notes under an existing ... principal amount of Senior Notes due 2020 on May ... offering and the previously issued Senior Notes due 2020 will ...
(Date:7/29/2010)... 2010 SynCo Bio Partners today,announced an ... recent initiation of a Phase 1 clinical trial in ... VRS-859. This news,comes less than 12 months since the ... product VRS-859 (exenatide-XTEN). , ... ...
(Date:7/29/2010)... July 29 Omeros Corporation (Nasdaq: ... committed equity financing facility under which it may sell ... of common stock to Azimuth Opportunity, Ltd. (the "investor") ... use the facility and remains free to enter into ... Omeros intends to use the proceeds from future sales ...
(Date:7/29/2010)... for Study to Identify Host Correlates of Protection Against Tuberculosis , ... OTTAWA, July ... for biological sample collection, stabilization and preparation, today announced that the ... Initiative (SATVI), has chosen Oragene-DNA for a study aimed at identifying ... , , ...
Breaking Biology Technology:Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020 2Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020 3SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials 2SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials 3Omeros Secures $40 Million Committed Equity Financing Facility 2Omeros Secures $40 Million Committed Equity Financing Facility 3Omeros Secures $40 Million Committed Equity Financing Facility 4DNA Genotek's Oragene-DNA Achieves 95% Compliance Rate in South African Tuberculosis Vaccine Initiative (SATVI) 2DNA Genotek's Oragene-DNA Achieves 95% Compliance Rate in South African Tuberculosis Vaccine Initiative (SATVI) 3
... , HOMOGENEOUS ASSAY , , ... PROCEDURE , , COMPATIBLE WITH MORE TARGETS ... , The ... detecting changes,in intracellular calcium concentration.,Specifically, this fast and simple fluorescencebased,assay allows the ...
... Evelyn McGown, Ph.D. and Michael Su, M.S., ... Molecular Devices Corporation, 8/00 , , ... many aspects of molecular biology. Of thespectrophotometric methods available, UV ... gained widespread popularity in the microplateformat. 1 However, A ...
... Inc., 6519 Dumbarton Circle, Fremont, CA 94555. , ... in siRNA-mediated gene expression knockdown studies is the validation ... Molecular Devices LMax II 384 microplate luminometer were ... following siRNA treatment. Quantitative assessment of the knockdown discerned ...
Other Biology Technology:Calcium Plus Assay Kit, Superior Detection for Specialized Targets 2Calcium Plus Assay Kit, Superior Detection for Specialized Targets 3DNA Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #37) 2DNA Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #37) 3DNA Quantitation in the LMax Microplate Luminometer (MaxLine Application Note #37) 4Measuring siRNA-mediated knockdown of IL-8 mRNA 2Measuring siRNA-mediated knockdown of IL-8 mRNA 3Measuring siRNA-mediated knockdown of IL-8 mRNA 4
(Date:7/29/2010)... 2010): Today, the Association for Molecular Pathology (AMP) submitted ... made by the National Institutes of Health (NIH) for ... survey of its membership to formulate a comprehensive response ... respondents working in a clinical laboratory setting, AMP is ... to the GTR, including insight to the community,s concerns ...
(Date:7/29/2010)... "white graphene" may be the perfect sidekick for ... in nanoscale electronics. , But single-atom-thick layers of ... study at Rice University,s world-class Department of Mechanical ... some macro applications as well. , Researchers in ... and Mary Greenwood Anderson Professor in Mechanical Engineering ...
(Date:7/29/2010)... JOLLA, CA July 28, 2010 For Immediate ... of a molecule normally produced in the brain may ... therapies for the treatment of epileptic seizures, according to ... Institute. , "This compound really provides a new ... Research Assistant Professor Xiaoying Lu, who co-authored the paper ...
Breaking Biology News(10 mins):AMP responds to Genetic Test Registry request for information 2'White graphene' to the rescue 2Scripps research study opens the door to new class of drugs for epileptic seizures 2Scripps research study opens the door to new class of drugs for epileptic seizures 3Reprogrammed human blood cells show promise for disease research 14232 1Reprogrammed human blood cells show promise for disease research 14232 2Reprogrammed human blood cells show promise for disease research 14232 3Fighting Off the Freshman Fifteen 74293 1Fighting Off the Freshman Fifteen 74293 2Fighting Off the Freshman Fifteen 74293 3DecafaLife LLC Announces New All Natural Product to Keep You Energized While Kicking Your Caffeine Habit 74288 1DecafaLife LLC Announces New All Natural Product to Keep You Energized While Kicking Your Caffeine Habit 74288 2
... new study highlights the role of a charge-switching enzyme ... other related neurological illness. , Multiple sclerosis (MS) ... the insulator for electrical signaling in the nervous system ... and nerve function. Much like the rubber insulation ...
... system and the self-cleaning system by which biological cells ... day yield new weapons in the fight against tuberculosis ... Department of Energy,s (DOE) Lawrence Berkeley National Laboratory (Berkeley ... point to "cross-talk" between them. , In a collaboration ...
... Science Foundation (NSF) is funding a new program at ... and math undergraduates for teaching careers. , The ... College of Arts and Sciences at Case Western Reserve ... become high school math and science teachers. The nearly ...
Other Biology News:Multiple sclerosis research charges ahead with new mouse model of disease 2Proteomics study yields clues as to how tuberculosis might be thwarting the immune system 2Proteomics study yields clues as to how tuberculosis might be thwarting the immune system 3NSF grant to launch undergrads from Case Western Reserve into math and science teaching 2NSF grant to launch undergrads from Case Western Reserve into math and science teaching 3
... Clone/PAD: ZMD.478. Immunogen: Synthetic ... of the humanmouse and bovine Math-2. ... protein. Reactivity: Human Rat (positive ... rat B28 cell lysates and rat ...
...
solute carrier family 25, member 13 (citrin)...
Request Info...
Biology Products: